|
(Health-NewsWire.Net, March 26, 2022 ) The Cell Culture Media Market is meant to grow on a splendid note in the next decade. With technology creeping in, the time-consuming routine is being taken over by telehealth/e-Health records. Almost everything that was happening in person has been taken over by remote monitoring. This has helped in transcending the geographical barriers as well. These would be the trends concerning the Cell Culture Media Market in the future.
According to a recent study by Persistence Market Research, the global cell culture media market is anticipated to witness high growth over the coming years. The market is predicted to grow from US$ 2.6 Bn in 2020 to over US$ 5.6 Bn by 2031. This reveals a CAGR of around 7.1% for the forecast period (2021-2031).
Also, biopharmaceuticals have fewer side effects because of their specificity, unlike conventional drugs that affect multiple systems. Biopharma is helping doctors in treating various diseases such as diabetes and cancer, because it allows clinicians to give specialized treatment to the specific medical problems of each patient.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/31338
With increasing demand for regenerative medicines, sale of cell culture media also increases. It is because regenerative medicine is that branch of medicine that develops methods to regrow, heal or replace injured or unhealthy cells, organs, and tissues.
Company Profiles:
Thermo Fisher Scientific Inc.
Merck KGaA
GE Healthcare
Lonza
Corning Incorporated
Irvine Scientific
STEMCELL Technologies Inc
PAN Biotech
MP Biomedicals, LLC
PromoCell GmbH
Becton, Dickinson and Company
Hi-Media Laboratories
Request for Methodology@ https://www.persistencemarketresearch.com/methodology/31338
Key Takeaways from Market Study
By product, serum-free media holds a high share of 51.4% in 2021. Serum-free media is mainly used due to minimize the risk of contamination.
By application, cancer research of cell culture media accounts for 43.7% market share.
By end-user, biopharmaceutical companies account for 83.3% of the market share, indicating rising demand for stem cells and tissue engineering.
By region, North America holds the largest share of 32.6% of the global cell culture media market.
“Increasing production of antibodies for the treatment of diseases and rising prevalence of cancer are expected to drive the demand of cell culture media over the decade,” says a Persistence Market Research analyst.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/31338
Who is Winning?
Some of the chief manufacturers of cell culture media are focusing on product launches, collaborations, and acquisitions for global expansion objectives, thereby enhancing their market presence.
In March 2021, PromoCell launched the improved 3rd generation melanocyte cell culture portfolio.
In May 2018, MP Biomedicals announced that it gained approval from the General Administration of Quality Supervision, Inspection, and Quarantine of the People’s Republic of China (AQSIQ), to export bovine blood products to China.
In 2019, PAN Biotech announced its plan of expansion for the export of fetal bovine serum globally.
Key market players covered in this research include GE Healthcare, Thermo Fisher Scientific, Merck KGaA, Lonza, Corning Incorporated, Irvine Scientific, STEMCELL Technologies Inc., and PAN Biotech.
Want More Valuable Insights?
Persistence Market Research brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global cell culture media Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
The study provides compelling insights into the cell culture media market. The market is segmented into five parts based on product (serum containing media, serum-free media, protein free media, and chemically defined media) based on application (cancer research, biopharmaceuticals, regenerative medicine & tissue engineering, stem cell technologies, and others) based on the end user (biopharmaceutical companies, clinical research organizations, and academic research centers), and across seven major regions.
Access Related Reports-
Life Science Market-
The global life-science products market is expected to grow 1.4x by 2024 end as compared to that in 2016, primarily due to investments in R&D & demand for high-quality products.
Fluoroscopy And C Arms Market-
The global Fluoroscopy & C – Arms market is likely to exhibit a CAGR of 4.5% during 2016–2024 with market revenue expected to increase from US$ 2,901.3 Mn in 2015 to US$ 4,290.5 Mn by 2024.
Leadless Pacing System Market-
The global market for leadless pacing systems is estimated to be valued at US$ 29.4 Mn in 2017 and is projected to grow at a CAGR of 10.0% during the forecast period.
Sleep Aid Devices Market-
The global Sleep Aid Devices Market is anticipated to account for over US$ 29,200 Mn, in terms of value, by 2026 end. The report on the sleep aid devices market further projects significant growth potential with CAGR at 4.9% through 2026.
About Us-
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Persistence Market Research
Atul Singh
+1-646-568-7751
atul@persistencemarketresearch.com
Source: EmailWire.Com 
|
